- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of preterm birth
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 816KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 50KB)
Progesterone – November 2021
Progesterone: Pessary 200 mg; Oripro®
Last updated
4 March 2022